Theravance Biopharma Statistics
Total Valuation
TBPH has a market cap or net worth of $531.01 million. The enterprise value is $448.32 million.
Important Dates
The next estimated earnings date is Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TBPH has 50.00 million shares outstanding. The number of shares has decreased by -4.72% in one year.
| Current Share Class | 50.00M |
| Shares Outstanding | 50.00M |
| Shares Change (YoY) | -4.72% |
| Shares Change (QoQ) | +0.81% |
| Owned by Insiders (%) | 7.74% |
| Owned by Institutions (%) | 41.18% |
| Float | 21.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 21.76 |
| PS Ratio | 8.01 |
| Forward PS | 5.58 |
| PB Ratio | 3.20 |
| P/TBV Ratio | 3.20 |
| P/FCF Ratio | 16.45 |
| P/OCF Ratio | 16.33 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.87 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 13.89 |
Financial Position
The company has a current ratio of 4.77, with a Debt / Equity ratio of 0.29.
| Current Ratio | 4.77 |
| Quick Ratio | 4.64 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | 1.49 |
| Interest Coverage | -17.84 |
Financial Efficiency
Return on equity (ROE) is -31.46% and return on invested capital (ROIC) is -12.22%.
| Return on Equity (ROE) | -31.46% |
| Return on Assets (ROA) | -7.98% |
| Return on Invested Capital (ROIC) | -12.22% |
| Return on Capital Employed (ROCE) | -14.63% |
| Revenue Per Employee | $672,845 |
| Profits Per Employee | -$601,371 |
| Employee Count | 97 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TBPH has paid $9.98 million in taxes.
| Income Tax | 9.98M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +26.10% in the last 52 weeks. The beta is -0.08, so TBPH's price volatility has been lower than the market average.
| Beta (5Y) | -0.08 |
| 52-Week Price Change | +26.10% |
| 50-Day Moving Average | 9.67 |
| 200-Day Moving Average | 9.19 |
| Relative Strength Index (RSI) | 57.31 |
| Average Volume (20 Days) | 325,675 |
Short Selling Information
The latest short interest is 3.79 million, so 7.58% of the outstanding shares have been sold short.
| Short Interest | 3.79M |
| Short Previous Month | 4.03M |
| Short % of Shares Out | 7.58% |
| Short % of Float | 17.51% |
| Short Ratio (days to cover) | 13.08 |
Income Statement
In the last 12 months, TBPH had revenue of $65.27 million and -$58.33 million in losses. Loss per share was -$1.19.
| Revenue | 65.27M |
| Gross Profit | 28.02M |
| Operating Income | -45.66M |
| Pretax Income | -38.22M |
| Net Income | -58.33M |
| EBITDA | -43.97M |
| EBIT | -45.66M |
| Loss Per Share | -$1.19 |
Full Income StatementBalance Sheet
The company has $130.86 million in cash and $48.16 million in debt, giving a net cash position of $82.70 million or $1.65 per share.
| Cash & Cash Equivalents | 130.86M |
| Total Debt | 48.16M |
| Net Cash | 82.70M |
| Net Cash Per Share | $1.65 |
| Equity (Book Value) | 165.98M |
| Book Value Per Share | 3.32 |
| Working Capital | 118.76M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $32.53 million and capital expenditures -$241,000, giving a free cash flow of $32.29 million.
| Operating Cash Flow | 32.53M |
| Capital Expenditures | -241,000 |
| Free Cash Flow | 32.29M |
| FCF Per Share | $0.65 |
Full Cash Flow StatementMargins
Gross margin is 42.93%, with operating and profit margins of -69.96% and -89.38%.
| Gross Margin | 42.93% |
| Operating Margin | -69.96% |
| Pretax Margin | -74.08% |
| Profit Margin | -89.38% |
| EBITDA Margin | -67.37% |
| EBIT Margin | -69.96% |
| FCF Margin | 49.47% |
Dividends & Yields
TBPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.72% |
| Shareholder Yield | 4.72% |
| Earnings Yield | -10.99% |
| FCF Yield | 6.08% |
Analyst Forecast
The average price target for TBPH is $14.50, which is 36.41% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.50 |
| Price Target Difference | 36.41% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 30.80% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TBPH has an Altman Z-Score of -2.33 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -2.33 |
| Piotroski F-Score | 3 |